Aptargroup Intrinsic Value Calculation – Cambridge Investment Research Advisors Reduces Stake in AptarGroup,
June 1, 2023
🌥️Trending News
APTARGROUP ($NYSE:ATR): AptarGroup, Inc., a global leader in packaging, dispensing, and sealing solutions, recently experienced a decrease in Cambridge Investment Research Advisors Inc.’s stake of shares. AptarGroup, Inc. is an international company that specializes in the design and manufacture of high-performance dispensing, dosing, and sealing solutions. They provide packaging solutions for personal care, healthcare, food & beverage, home care and other niche markets worldwide. The company focuses on creating tailored solutions that meet the needs of their customers and enable them to differentiate their products in the marketplace.
Their products range from pumps, valves, and closures for cosmetics and personal care products to aerosol valves and actuators for the health & beauty and home care markets. Their innovative technology helps customers to reduce product leakage, prevent over-dosing, and produce precise results.
Stock Price
On Tuesday, AptarGroup, Inc.’s stock opened at $114.2 and closed at $113.4, resulting in a 0.7% decrease from its prior closing price of $114.2. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Aptargroup. More…
| Total Revenues | Net Income | Net Margin |
| 3.34k | 231.63 | 7.3% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Aptargroup. More…
| Operations | Investing | Financing |
| 484.84 | -316.4 | -398.85 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Aptargroup. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 4.3k | 2.18k | 32.31 |
Key Ratios Snapshot
Some of the financial key ratios for Aptargroup are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 5.6% | 0.4% | 10.9% |
| FCF Margin | ROE | ROA |
| 4.9% | 10.9% | 5.3% |
Analysis – Aptargroup Intrinsic Value Calculation
GoodWhale recently performed an analysis of APTARGROUP‘s wellbeing. Our proprietary Valuation Line indicated that the fair value of APTARGROUP’s share is roughly $121.1. Currently, APTARGROUP’s stock is trading at $113.4, which is a fair price but undervalued by 6.4%. This implies that investors may want to consider buying APTARGROUP shares as there could be an upside potential. More…
Peers
The competition between AptarGroup Inc and Sonova Holding AG, Bruker Corp, West Pharmaceutical Services Inc is fierce. Each company is striving to be the best in the industry, and they are all constantly innovating and improving their products and services. This competition is good for consumers, as it drives down prices and forces the companies to be at the top of their game.
– Sonova Holding AG ($LTS:0QPY)
Sonova Holding AG is a world leader in providing solutions for people with hearing loss. The company has a market capitalization of 14.2 billion as of 2022 and a return on equity of 27.55%. Sonova’s products and services are available in more than 100 countries and include cochlear implants, hearing aids, wireless communication systems, and software applications. The company’s mission is to provide people with the best possible hearing solutions and to enable them to lead fulfilling lives.
– Bruker Corp ($NASDAQ:BRKR)
Bruker Corporation is a leading manufacturer of scientific instruments and solutions. The company produces a wide range of products for a variety of applications, including healthcare, industrial and scientific research, and security. Bruker’s products are used by customers around the world, and the company has a strong presence in both developed and emerging markets. The company’s market capitalization is 8.14 billion as of 2022, and its return on equity is 29.41%. Bruker is a publicly traded company, and its shares are listed on the Nasdaq Stock Market.
– West Pharmaceutical Services Inc ($NYSE:WST)
West Pharmaceutical Services Inc is a leading manufacturer of pharmaceutical packaging components and delivery systems. The company has a market cap of 18.33B as of 2022 and a Return on Equity of 20.68%. West Pharmaceutical Services Inc is a global leader in the design and manufacture of innovative, high-quality pharmaceutical packaging components and delivery systems. The company’s products are used by pharmaceutical, biotechnology and healthcare companies to improve patient safety and outcomes.
Summary
AptarGroup, Inc is a firm specializing in the manufacturing of consumer products packaging and dispensing solutions. Recently, Cambridge Investment Research Advisors Inc. sold off a portion of their shares in the company, indicating that they may no longer have faith in the company’s stock performance. Investors should take this into consideration when making decisions regarding AptarGroup, Inc’s stock. Analysts recommend researching the company’s financials before investing in order to gain insight into the company’s financial health and outlook.
Additionally, any major developments or changes in the company’s operations or news should be monitored closely. Investors should also account for the company’s competitive landscape when assessing potential investments.
